MICSI

About MICSI

MICSI operates in the Other / Uncategorized space and is among the firms Bracken expects to track at SNMMI 2026.

Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.

What we're seeing

• FierceBiotech · 2026-07-18
  Micsi appoints new Chief Medical Officer ahead of pivotal trial
  The work builds on more than a decade of radiochemistry collaboration.
• BioPharma Reporter · 2026-12-21
  Micsi signs supply agreement to support late-stage trials
  Industry observers expect more activity of this kind in the run-up to SNMMI 2026.
• Reuters Health · 2026-09-16
  Micsi expands cyclotron capacity to meet Lu-177 demand
  The announcement comes amid tightening Mo-99 and Lu-177 supply.
• Endpoints News · 2026-06-07
  Micsi announces Phase II readout for lead theranostic candidate
  The work builds on more than a decade of radiochemistry collaboration.
• Nuclear Medicine Today · 2026-07-18
  Micsi files IND for next-generation PSMA-targeted agent
  Industry observers expect more activity of this kind in the run-up to SNMMI 2026.

Mocked while we wire the Exa integration. Headlines are illustrative.

What we expect to see at the booth

Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.